RU2014119669A - METHOD OF SUBSTRATE MUSCULAR BLOCKADE - Google Patents

METHOD OF SUBSTRATE MUSCULAR BLOCKADE Download PDF

Info

Publication number
RU2014119669A
RU2014119669A RU2014119669A RU2014119669A RU2014119669A RU 2014119669 A RU2014119669 A RU 2014119669A RU 2014119669 A RU2014119669 A RU 2014119669A RU 2014119669 A RU2014119669 A RU 2014119669A RU 2014119669 A RU2014119669 A RU 2014119669A
Authority
RU
Russia
Prior art keywords
substrate
blockade
subscapularis muscle
muscular
muscular blockade
Prior art date
Application number
RU2014119669A
Other languages
Russian (ru)
Inventor
Альбина Эмильевна Батуева
Владимир Николаевич Батуев
Original Assignee
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" (национальный исследовательский университет) (ФГБОУ ВПО "ЮУрГУ" (НИУ))
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" (национальный исследовательский университет) (ФГБОУ ВПО "ЮУрГУ" (НИУ)) filed Critical Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" (национальный исследовательский университет) (ФГБОУ ВПО "ЮУрГУ" (НИУ))
Priority to RU2014119669A priority Critical patent/RU2014119669A/en
Publication of RU2014119669A publication Critical patent/RU2014119669A/en

Links

Abstract

Способ блокады подлопаточной мышцы, характеризующийся тем, что выявляют точки максимальной болезненности в области брюшка укороченной подлопаточной мышцы и вводят в них препарат Траумель C, при этом курс лечения состоит из 3-5 блокад по 2-3 процедуры в неделю.The method of blockade of the subscapularis muscle, characterized in that the point of maximum pain in the abdomen of the shortened subscapularis muscle is detected and the drug Traumeel C is injected into them, while the course of treatment consists of 3-5 blocks of 2-3 procedures per week.

Claims (1)

Способ блокады подлопаточной мышцы, характеризующийся тем, что выявляют точки максимальной болезненности в области брюшка укороченной подлопаточной мышцы и вводят в них препарат Траумель C, при этом курс лечения состоит из 3-5 блокад по 2-3 процедуры в неделю. The method of blockade of the subscapularis muscle, characterized in that the point of maximum pain in the abdomen of the shortened subscapularis muscle is detected and the drug Traumeel C is injected into them, while the course of treatment consists of 3-5 blocks of 2-3 procedures per week.
RU2014119669A 2014-05-15 2014-05-15 METHOD OF SUBSTRATE MUSCULAR BLOCKADE RU2014119669A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014119669A RU2014119669A (en) 2014-05-15 2014-05-15 METHOD OF SUBSTRATE MUSCULAR BLOCKADE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014119669A RU2014119669A (en) 2014-05-15 2014-05-15 METHOD OF SUBSTRATE MUSCULAR BLOCKADE

Publications (1)

Publication Number Publication Date
RU2014119669A true RU2014119669A (en) 2016-01-10

Family

ID=55071800

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014119669A RU2014119669A (en) 2014-05-15 2014-05-15 METHOD OF SUBSTRATE MUSCULAR BLOCKADE

Country Status (1)

Country Link
RU (1) RU2014119669A (en)

Similar Documents

Publication Publication Date Title
CY1124368T1 (en) METHODS OF INCREASING TONIC INHIBITION AND TREATMENT OF ANGELMAN SYNDROME
EA201790766A1 (en) NEW METHILPIPERIDINE CONNECTIONS SUITABLE FOR INHIBITING MICROSOMAL PROSTAGLANDIN-E2-SYNTHASE 1
EA201691155A1 (en) COMBINATION INHIBITORS OF HISTONDEACETYLASE AND IMMUNOMODULATING MEDICINES
EA201790764A1 (en) NEW CARBON ACID CONNECTIONS SUITABLE FOR INHIBITING MICROSOMAL PROSTAGLANDIN-E2-SYNTHASE 1
EA201790142A1 (en) TREATMENT OF LEUKEMIA INHIBITORS HISTONDEACETYLASE
EA201591825A1 (en) THE ANTAGONISM OF MYOSTATIN IN SUBJECTS - PEOPLE
BR112017018964A2 (en) use of plinabulin and methods to treat brain tumor
HK1255243A1 (en) Transcutaneous electrical muscle stimulation device for the treatment of premature ejaculation or erectile dysfunction, and methods of use thereof
NZ729252A (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
CY1123366T1 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
EA201692284A1 (en) NIACINAMIDE FOR STIMULATING THE PRODUCTION OF ANTIMICROBIAL PEPTIDES
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
EA201792123A1 (en) PAIN TREATMENT
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EA201790912A1 (en) Heterocyclic Compound
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
EA202190281A1 (en) DERIVATIVES 3 - ((HETERO-) ARYL) -8-AMINO-2-OXO-1,3-DIAZA-SPIRO [4,5] DECANE
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
EA201790352A1 (en) THERAPEUTIC TREATMENT BASED ON ANAMORELIN
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EA201792560A1 (en) NANOPARTICLES FOR APPLICATION AS A THERAPEUTIC VACCINE
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
EA201691796A1 (en) N-SUBSTITUTED ASYMMETRIC UREA AND THEIR APPLICATION IN MEDICINE